POLANSKY V. EXECUTIVE HEALTH RESOURCES INC.

CourtDistrict Court, E.D. Pennsylvania
DecidedNovember 5, 2019
Docket2:12-cv-04239
StatusUnknown

This text of POLANSKY V. EXECUTIVE HEALTH RESOURCES INC. (POLANSKY V. EXECUTIVE HEALTH RESOURCES INC.) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
POLANSKY V. EXECUTIVE HEALTH RESOURCES INC., (E.D. Pa. 2019).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA

JESSE POLANSKY M.D., M.P.H., et al.

v. CIVIL ACTION

EXECUTIVE HEALTH RESOURCES, NO. 12-CV-4239 INC., et al.

FINAL MEMORANDUM

Baylson, J. November 5, 2019

I. INTRODUCTION Jesse Polansky (“Relator”) brings this False Claims Act qui tam1 action on behalf of the United States alleging that Executive Health Resources, Inc. (“Defendant”) caused its client hospitals to fraudulently bill Medicare and Medicaid by falsely designating patient admissions as inpatient when they should have been marked as outpatient. This case, which was filed over seven years ago, has an extensive procedural history. Presently before the Court is the Government’s Motion to Dismiss, as well as the briefs submitted by the parties following the Court’s Order of September 26, 2019, (ECF 550), invoking FED. R. CIV. P. 56(f) and giving notice of possible entry of summary judgment on other grounds.

1 The False Claims Act was “originally aimed principally at stopping the massive frauds perpetrated by large contractors during the Civil War.” United States v. Bornstein, 423 U.S. 303, 309 (1976). The qui tam provision of the False Claims Act permits “a private person, known as a relator, … [to bring an action] ‘for the person and for the United States Government … in the name of the Government.’” Cochise Consultancy, Inc. v. Hunt, 139 S. Ct. 1507, 1510 (2019) (quoting 31 U.S.C. § 3730(b)). II. BACKGROUND A. Case History2 Relator filed his Complaint under seal on July 26, 2012 in accordance with the False Claims Act (“FCA”), 31 U.S.C. § 3729 et seq. (ECF 1.) Relator twice amended his Complaint, (ECF 9;

ECF 12) before the Government declined to intervene on June 27, 2014, (ECF 19.) Thereafter, pursuant to the FCA, Relator served the then-operative Complaint on Defendant and proceedings commenced before the Honorable Thomas O’Neill, who issued an extensive Memorandum and Order denying the Defendant’s Motion to Dismiss on July 26, 2016. (ECF 103.) The following year, after Judge O’Neill’s death, the case was transferred to the undersigned. (ECF 141.) The core of Relator’s theory of liability is that Defendant exploited the difference in reimbursement rates for inpatient and outpatient services,3 causing hundreds of thousands of claims for medical services to be billed as inpatient when they should have been billed as outpatient.4 It became obvious to the Court, and was not seriously contested by Relator or Defendant, that the best way to adjudicate this case was to hold a bellwether trial on a limited number of claims.5 Following multiple submissions and conferences, the Court entered an order

2 Unless the name of the docket entry is relevant to this Memorandum, the Court will refer to docket entries solely by their assigned number. 3 According to Relator, “Medicare generally pays about $4,500-$5,000 more for inpatient services … than it does when the same services are provided to a patient classified as outpatient observation.” (ECF 429, Ex. A., Third Am. Compl. ¶ 66) (“Third Am. Compl.”). 4 For a comprehensive description of the scheme, see Polansky v. Exec. Health Res., Inc., 196 F. Supp. 3d 477, 484- 88 (E.D. Pa. 2016) (O’Neill, J.). As summarized by Judge O’Neill, there are two potential levels of review for a physician’s initial determination of whether a patient should be classified as inpatient or outpatient. At the first level, a review is conducted by an internal hospital committee using standard industry criteria. Id. at 485. If the internal committee determines that a patient does not qualify for inpatient designation, many hospitals then have a physician advisor, such as Defendant, conduct a second level review. Id. After physician advisor review, the hospital—not the physician advisor—submits the claim for reimbursement to Medicare or Medicaid. (Am. Compl. ¶ 115.) Relator alleges that Defendant, as a physician advisor conducting second level reviews (i.e., reviewing the determination of the internal review committee that a patient does not qualify for inpatient status), “knowingly misconstrue[d] … regulations when … review[ing] hospital admission determinations, fraudulently certifying ‘thousands upon thousands of cases’ for hospitals to submit to Medicare and Medicaid as inpatient claims rather than outpatient as appropriate.” Polansky, 196 F. Supp. 3d at 485. 5 See generally MELISSA J. WHITNEY, BELLWETHER TRIALS IN MDL PROCEEDINGS: A GUIDE FOR TRANSFEREE JUDGES (2019). requiring the parties to select a limited number of claims for discovery, following which a smaller number of claims would be selected for a bellwether trial. (ECF 240.) The Court eventually held that each party would select specified claims for itself and other claims would be chosen randomly for discovery. This procedure was designed to result in a jury trial where the jury would answer

interrogatories as to whether Relator had proven Defendant violated the FCA by seeking and accepting improper reimbursements, and the Court would enter judgment on all other claims encompassed by the jury verdict after the bellwether trial. For pretrial management, the case was divided into two segments. The first segment, “Phase I,” was designed to adjudicate reimbursement claims certified by Defendant from January 1, 2009 to October 1, 2013.6 The second segment, the “Two Midnight” phase, was designed to address Relator’s reimbursement claims for events that occurred after October 1, 2013, on which date the Centers for Medicare and Medicaid Services (“CMS”) implemented a new reimbursement regime—the Two Midnight Rule.7 In short, the Two Midnight Rule requires that, to admit an individual as an inpatient, the admitting physician expects that the patient’s stay will cross two midnights.8

Extensive discovery proceeded with several motions filed by both parties, which the Court attempted to resolve fairly and promptly.9 During the course of this discovery, Relator’s conduct

6 Relator seeks to prove liability for Phase 1 certifications that meet the following criteria: “(a) For beneficiaries whose length of stay after the inpatient admission was (1) day or less; and (b) The medical record does not demonstrate that there was a reasonable basis at the time of the inpatient order for the treating physician to expect a medically necessary hospital stay of 24 hours or longer.” (Third Am. Compl. ¶¶ 364; 379.) 7 After a notice and comment period, CMS published the final version of the Two Midnight Rule on August 19, 2013, effective beginning October 1, 2013. Two Midnight Rule, 78 Fed. Reg. 50,496 (Aug. 19, 2013) (codified as amended 42 C.F.R. § 412.3(d)(1)). 8 The full Regulation reads: “[A]n inpatient admission is generally appropriate for payment under Medicare Part A when the admitting physician expects the patient to require hospital care that crosses two midnights.” 42 C.F.R. § 412.3(d)(1). 9 On February 21, 2019, the Court appointed a Special Master—Sandra Jeskie, an expert on electronically stored information (“ESI”)—to oversee discovery issues. (ECF 399.) The majority of discovery that has been conducted to date dealt with Relator’s Phase 1 claims, though some discovery has been taken on the Two Midnight claims as well. interrupted the intended discovery; his behavior was material and plays a role in the final disposition of this case.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Bornstein
423 U.S. 303 (Supreme Court, 1976)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Ridenour v. Kaiser-Hill Co.
397 F.3d 925 (Tenth Circuit, 2005)
Swift, Susan v. United States
318 F.3d 250 (D.C. Circuit, 2003)
United States Ex Rel. Wickliffe v. EMC Corp.
473 F. App'x 849 (Tenth Circuit, 2012)
Cedars-Sinai Medical Center v. Shalala
939 F. Supp. 1457 (C.D. California, 1996)
United States Ex Rel. Stierli v. Shasta Services Inc.
440 F. Supp. 2d 1108 (E.D. California, 2006)
In Re Chocolate Confectionary Antitrust Litigation
801 F.3d 383 (Third Circuit, 2015)
United States v. Sanford-Brown, Limited
840 F.3d 445 (Seventh Circuit, 2016)
United States Ex Rel. Kelly v. Serco, Inc.
846 F.3d 325 (Ninth Circuit, 2017)
United States Ex Rel. Petratos v. Genentech Inc.
855 F.3d 481 (Third Circuit, 2017)
Allina Health Services v. Thomas Price
863 F.3d 937 (D.C. Circuit, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
POLANSKY V. EXECUTIVE HEALTH RESOURCES INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/polansky-v-executive-health-resources-inc-paed-2019.